SABS

SAB BIOTHERAPEUTICS INC

SABS·78397T202·US·Common Stock·Healthcare - Biotechnology-Activist

SABS (SAB BIOTHERAPEUTICS INC) is held by 56 institutional investors as of Q2 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($25M), RA CAPITAL MANAGEMENT, L.P. ($17.2M), BALYASNY ASSET MANAGEMENT L.P. ($14.7M). Net institutional sentiment: Bullish.

56
Holders
(2 Elite)
$123.8M
Total Value
68% (63)
Consensus
43 buying - 20 selling
13F: Insider & Congress: Updated regularly
SABS

Smart Money Verdict

View all
Loading verdict
Held by 56 funds
2 elite

Who's Trading

Source dates: Price Aug 18, 2026 · Insiders none · Activists Aug 14, 2026 · Congress none

ActivistPAPerceptive Advisors LLC7.3%Aug 14, 2026
ActivistBALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.9.4%Aug 14, 2026
ActivistCOCommodore Capital LP9.9%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6.4M(+88.1%)$25M0.0%-2.69%
45
Unchanged
4.4M$17.2M0.1%+94.36%
0
Unchanged
3.8M$14.7M0.0%-2.19%
0
Increased
3.1M(+917.5%)$12M0.0%-2.80%
45
Increased
3M(+19.2%)$11.6M0.0%-2.61%
33
Decreased
2.7M(-9.3%)$10.7M0.0%-2.25%
0
Increased
1.3M(+322.9%)$5M0.0%-43.34%
43
Decreased
1.2M(-58.6%)$4.6M0.0%+94.30%
0
Decreased
1.2M(-14.8%)$4.6M0.0%-2.57%
0
Decreased
611,019(-58.6%)$2.4M0.0%-1.99%
0
Increased
530,831(+615.1%)$2.1M0.0%-2.71%
42
New
438,515$1.7M0.0%-2.82%
36
Increased
373,980(+89.2%)$1.5M0.0%-2.69%
40
Increased
365,878(+684.8%)$1.4M0.0%-1.70%
41
Increased
362,489(+531.2%)$1.4M0.0%-2.94%
41
Unchanged
307,500$1.2M0.0%+94.36%
0
New
292,728$1.1M0.0%-2.82%
35
Increased
214,632(+18.5%)$837,0650.0%-2.61%
29
Increased
191,305(+67.9%)$746,0890.0%+0.93%
36
New
107,847$420,6040.0%-2.82%
33

Showing 1-20 of 68

1 / 4
SABSSABSSAB BIOTHERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used